Zobrazeno 1 - 10
of 39
pro vyhledávání: '"M De La Rubia Navarro"'
Autor:
JA Roman Ivorra, M de la Rubia Navarro, I Canovas Olmos, R Gonzalez Mazario, L Gonzalez Puig, E Grau Garcia, I Martinez Cordellat, C Najera Herranz, R Negueroles Albuixech, E Vicens Bernabeu, C Riesco Barcena, S Leal Rodríguez, C Pávez Perales, AV Huaylla Quispe, P Muñoz Martínez, L Mas Sánchez, J Oller Rodríguez, JR Ivorra Cortes, J Fragio Gil
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/087483246dae4e9e8070638d028c5edd
Autor:
JA Roman Ivorra, M de la Rubia Navarro, I Canovas Olmos, L Gonzalez Puig, E Grau Garcia, I Martinez Cordellat, R Negueroles Albuixech, JE Oller Rodriguez, E Vicens Bernabeu, C Riesco Barcena, S Leal Rodríguez, C Pávez Perales, AV Huaylla Quispe, P Muñoz Martínez, L Mas Sánchez, JR Ivorra Cortes, C Herranz Najera, OS Francisco Miguel, J Fragio Gil
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/b9817730e6d34df8b728ac1fc761f293
Autor:
M De La Rubia Navarro, E Grau Garcia, C Pavez Perales, JR Ivorra Cortes, L Gonzalez Puig, R Negueroles Albuixech, I Martinez Cordellat, C Herranz Najera, OS Francisco Miguel, J Fragio Gil, I Canovas Olmos, E Vicens Bernabeu, JE Oller Rodriguez, S Leal Rodriguez, C Riesco Barcena, AV Huaylla Quispe, L Mas Sanchez, P Muñoz Martinez, JA Roman Ivorra
Publikováno v:
Thursday 06 October 2022 from 13:00 to 14:10.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37a27c39ecccb96e1895d63f9a7ce1ef
https://doi.org/10.1136/lupus-2022-elm2022.91
https://doi.org/10.1136/lupus-2022-elm2022.91
Autor:
M De La Rubia Navarro, E Grau Garcia, C Pavez Perales, S Leal Rodriguez, C Riesco Barcena, AV Huaylla Quispe, JR Ivorra Cortes, L Gonzalez Puig, R Negueroles Albuixech, I Martinez Cordellat, C Najera Herranz, J Fragio Gil, R Gonzalez Mazario, I Canovas Olmos, E Vicens Bernabeu, J Oller Rodriguez, L Mas Sanchez, P Muñoz Martinez, JA Roman Ivorra
Publikováno v:
Friday 07 October 2022 from 13:00 to 14:10.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::119a1044cdb987118c07d7b053755292
https://doi.org/10.1136/lupus-2022-elm2022.138
https://doi.org/10.1136/lupus-2022-elm2022.138
Autor:
E Grau García, L Gomez-Lechón Quirós, C Riesco Barcena, AV Huaylla Quispe, S Leal Rodríguez, C Pávez Perales, L Mas Sanchez, P Muñoz Martínez, M De La Rubia Navarro, I Cánovas Olmos, J Ivorra Cortés, JJ Fragio Gil, L González Puig, I Martínez Cordellat, C Nájera Herranz, R Negueroles Albuixech, JE Oller Rodríguez, FM Ortiz-Sanjuán, E Vicens Bernabéu, JA Roman Ivorra
Publikováno v:
Thursday 06 October 2022 from 13:00 to 14:10.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::464e96436327d7bb0f81bf32ed5654d4
https://doi.org/10.1136/lupus-2022-elm2022.95
https://doi.org/10.1136/lupus-2022-elm2022.95
Autor:
C. Riesco Bárcena, S. Leal Rodriguez, M. E. Acosta, E. Grau García, C. Pávez Perales, A. V. Huaylla Quispe, M. De la Rubia Navarro, P. Muñoz Martinez, L. Mas Sanchez, I. Martínez Cordellat, C. Nájera Herranz, R. Negueroles Albuixech, F. Ortiz-Sanjuán, E. Vicens Bernabeu, I. Cánovas Olmos, J. J. Fragío Gil, L. Gonzalez Puig, J. E. Oller Rodríguez, J. Ivorra Cortés, J. A. Román Ivorra
Publikováno v:
Annals of the Rheumatic Diseases. 81:328-329
BackgroundDuring the first months of the Sars-CoV-2 pandemic, antimalarial drugs were the central axis of the treatment of patients with acute respiratory infection. After that, several studies reported a risk of prolongation of corrected QT interval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b67720982b59e9613917d9f7a3e8a243
https://doi.org/10.1136/annrheumdis-2022-eular.2847
https://doi.org/10.1136/annrheumdis-2022-eular.2847
Autor:
F. Ortiz-Sanjuán, S. Leal Rodriguez, E. Grau García, C. Riesco Barcena, A. V. Huaylla Quispe, C. Pávez Perales, M. De la Rubia Navarro, I. Martínez Cordellat, L. Mas Sanchez, P. Muñoz Martinez, C. Nájera Herranz, R. Negueroles Albuixech, J. E. Oller Rodríguez, E. Vicens Bernabeu, I. Cánovas Olmos, J. J. Fragío Gil, L. Gonzalez Puig, J. Ivorra Cortés, J. A. Román Ivorra
Publikováno v:
Annals of the Rheumatic Diseases. 81:250.2-250
BackgroundInterstitial lung disease (ILD) is a frequent complication of systemic sclerosis (SSc) and is often progressive and has a poor prognosis. A restrictive ventilatory defect could suggest ILD either alone or in combination with pulmonary arter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efe3c0f15224ce9040d60eb31151252c
https://doi.org/10.1136/annrheumdis-2022-eular.3085
https://doi.org/10.1136/annrheumdis-2022-eular.3085
Autor:
E. Grau García, J. J. Fragío Gil, R. González Mazarío, P. Muñoz Martinez, L. Mas Sanchez, C. Pávez Perales, S. Leal Rodriguez, A. V. Huaylla Quispe, C. Riesco Barcena, M. De la Rubia Navarro, F. Ortiz-Sanjuán, I. Martínez Cordellat, J. E. Oller Rodríguez, R. Negueroles Albuixech, J. Ivorra Cortés, L. Gonzalez Puig, E. Vicens Bernabeu, I. Cánovas Olmos, C. Nájera Herranz, J. A. Román Ivorra
Publikováno v:
Annals of the Rheumatic Diseases. 81:1334.1-1334
BackgroundGender differences in demographic and clinical features may have a direct impact in patient prognosis.ObjectivesWe aimed to investigate gender differences in disease manifestations, comorbidities and treatment among patients who had started
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b496e573ebb72b6506ab4613a94b26b9
https://doi.org/10.1136/annrheumdis-2022-eular.3917
https://doi.org/10.1136/annrheumdis-2022-eular.3917
Autor:
J. E. Oller Rodríguez, E. Grau García, S. Leal Rodriguez, P. Muñoz Martinez, L. Mas Sanchez, C. Riesco Barcena, A. V. Huaylla Quispe, C. Pávez Perales, M. De la Rubia Navarro, I. Martínez Cordellat, C. Nájera Herranz, R. Negueroles Albuixech, F. Ortiz-Sanjuán, E. Vicens Bernabeu, I. Cánovas Olmos, J. J. Fragío Gil, L. Gonzalez Puig, J. Ivorra Cortés, J. A. Román Ivorra
Publikováno v:
Annals of the Rheumatic Diseases. 81:1635.2-1635
BackgroundVertebral fractures entail a notorious social and health problem, and their presence is the greatest risk factor for the appearance of a new vertebral fracture. Despite the availability of different drugs for secondary prevention, there are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b6399a668a32862b960c2735dfc1384
https://doi.org/10.1136/annrheumdis-2022-eular.3312
https://doi.org/10.1136/annrheumdis-2022-eular.3312
Autor:
R. González Mazarío, J. J. Fragío Gil, L. Mas Sanchez, P. Muñoz Martinez, F. Ortiz-Sanjuán, C. Pávez Perales, S. Leal Rodriguez, C. Riesco Barcena, A. V. Huaylla Quispe, M. De la Rubia Navarro, L. Gonzalez Puig, E. Grau García, J. E. Oller Rodríguez, I. Martínez Cordellat, R. Negueroles Albuixech, E. Vicens Bernabeu, J. Ivorra Cortés, C. Nájera Herranz, I. Cánovas Olmos, J. A. Román Ivorra
Publikováno v:
Annals of the Rheumatic Diseases. 81:1286.1-1286
BackgroundRecent published data have emerged some concerns about safety of Janus kinase (JAK) inhibitors and FDA have established prescribing restrictions.ObjectivesThe aim of this study was to analyze the safety profile of current approved JAK inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::367a56c14def5a47b84f1c0681727e3b
https://doi.org/10.1136/annrheumdis-2022-eular.5038
https://doi.org/10.1136/annrheumdis-2022-eular.5038